Goldman Sachs
FRLN

Goldman Sachs’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

Goldman Sachs’s Portfolio FRLN Stock Details FRLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,121
Closed -$207K – 6604
2021
Q1 		$207K Hold
1,121
– – ﹤0.01% 5627
2020
Q4 		$307K Buy
+1,121
New +$282K ﹤0.01% 4875

Other funds holding FRLN

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs's FRLN Position: Q2 2021 in Review

Goldman Sachs sold out of Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) in Q2 2021, closing a stake of 1,121 shares — an estimated $207K sold.

Goldman Sachs first reported a position in FRLN in Q4 2020 and held it in 2 quarters. The position peaked at $307K in Q4 2020. 16 funds tracked by Wall St. Rank hold FRLN as of Q2 2021.

  • Goldman Sachs reported no remaining Freeline Therapeutics Holdings plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Goldman Sachs sold 1,121 Freeline Therapeutics Holdings plc American Depositary Shares shares in Q2 2021, an estimated $207K.
  • Goldman Sachs first reported a position in Freeline Therapeutics Holdings plc American Depositary Shares in Q4 2020 and held it in 2 quarters.
  • Goldman Sachs's Freeline Therapeutics Holdings plc American Depositary Shares position peaked at $307K in Q4 2020.
  • 16 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings plc American Depositary Shares as of Q2 2021.

Based on Goldman Sachs's 13F filing for Q2 2021, filed 13 Aug 2021.